Please use this identifier to cite or link to this item: http://hdl.handle.net/11690/3350
Authors: Antonio, Eduardo Cheuiche
Meireles, Mariana Rost
Bragatte, Marcelo Alves de Souza
Vieira, Gustavo Fioravanti
Title: Viral immunogenic footprints conferring T cell cross-protection to SARS-CoV-2 and its variants
Keywords: T-cell epitopes;Structural analysis;Cross-reactivity;Cellular response;Immuno informatics;SARS-CoV-2;Coronaviruses
Issue Date: 2022
Publisher: Frontiers
Citation: ANTONIO, E. C. et al. Viral immunogenic footprints conferring T cell cross-protection to SARS-CoV-2 and its variants. Frontiers in Immunology, v. 13, p. 1, 2022. Disponível em: https://www.frontiersin.org/articles/10.3389/fimmu.2022.931372/full. Acesso em: 05 out. 2022.
Abstract: COVID-19 brought scenes from sci-fi movies into real life. Infected individuals include asymptomatic cases to severe disease leading to death, suggesting the involvement of the genetic constitution of populations and pathogens contributing to differential individuals’ outcomes. To investigate shared immunogenic features between SARS-CoV-2 targets and other coronaviruses, we modeled their peptides in 3D structures of HLA-A*02:01 (pMHC), comparing their molecular surfaces These structures were also compared with a panel of epitopes from unrelated viruses, looking for potential triggers conferring cross-protection in uninfected individuals. As expected, SARS-CoV 1 and 2 peptides share molecular and physicochemical features, providing an explanation for the verified experimental immunogenicity among them. Surprisingly, even discordant sequences from human coronaviruses 229E, OC43 and epitopes from unrelated viruses involved in endemic human infections exhibit similar fingerprints of immunogenicity with SARS-CoV-2 peptides. The same approach indicates a conserved CD8+ T cell recognition between Wuhan SARS-CoV-2 sequences and altered peptides from Variants of Concern. Examination of structural data over epitope sequence analysis here could explain how previous infections may produce a heterologous immunity response in a global scale against emergent diseases such as Covid-19, mitigating its full lethal potential, and paves the way for the development of wide spectrum vaccine development.
Appears in Collections:Artigo de Periódico (PPGSDH)

Files in This Item:
File Description SizeFormat 
antonio.etal.pdfOpen Access4.84 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.